Tag - vaccinations

 
 

VACCINATIONS

Japan Times
WORLD
Dec 10, 2020
U.S. nears final COVID-19 vaccine review as daily deaths top 3,250
Steady movement toward a vaccine rollout on the eve of a critical review by leading U.S. medical experts comes as COVID-19 caseloads surged alarmingly higher, straining health care systems.
Japan Times
WORLD / Science & Health
Dec 10, 2020
U.K. issues anaphylaxis warning on Pfizer vaccine after adverse reactions
Britain began mass vaccinating its population on Tuesday, part of a global drive that poses one of the biggest logistical challenges in peacetime history.
Japan Times
WORLD / Science & Health
Dec 9, 2020
China’s state-backed coronavirus vaccine has 86% efficacy, says UAE
China’s state-backed coronavirus vaccine protected 86% of people from getting COVID-19 in trials conducted in the United Arab Emirates, reported media outlets including Reuters, citing the UAE’s health ministry.
Japan Times
WORLD / Science & Health
Dec 9, 2020
Testing times: More work needed on AstraZeneca/Oxford vaccine trials
A Lancet study gave few extra clues about why efficacy was 62% for trial participants given two full doses, but 90% for a smaller subgroup given a half, then a full dose.
Japan Times
WORLD / Science & Health
Dec 3, 2020
Why the U.K. approved a COVID-19 vaccine first
Doses of the Pfizer-BioNTech vaccine will be injected starting next week, the government said.
Japan Times
WORLD / Science & Health
Nov 29, 2020
U.K. poised to be first to approve Pfizer-BioNTech COVID-19 vaccine
The U.K. is poised to become the first country to approve Pfizer Inc. and BioNTech SE’s COVID-19 vaccine, ahead of a long line of countries waiting for protection from the coronavirus.
Japan Times
WORLD / Science & Health
Nov 26, 2020
After admitting error, AstraZeneca faces hard questions on vaccine
Scientists said a series of irregularities and omissions in the way AstraZeneca initially disclosed the data have eroded their confidence in the reliability of the results.
Japan Times
WORLD / Science & Health / FOCUS
Nov 24, 2020
Decades of work, and half a dose of fortune, drove Oxford vaccine success
The Oxford vaccinologists were exhilarated on Monday when drugmaker AstraZeneca, with whom they developed the shot, announced that it could be around 90% effective.
Japan Times
WORLD
Nov 23, 2020
U.S. plans first vaccinations in weeks, Operation Warp Speed chief says
Vaccinations against COVID-19 in the U.S. will "hopefully” start in less than three weeks, according to the head of the federal government’s program to accelerate a vaccine.
Japan Times
WORLD / Science & Health
Nov 21, 2020
Two companies say their vaccines are 95% effective. What does that mean?
You might assume that 95 out of every 100 people vaccinated will be protected from COVID-19. But that's not how the math works.
Japan Times
WORLD / Science & Health
Nov 19, 2020
Can first vaccines bring herd immunity? Experts have doubts.
Figuring out what's needed to achieve herd immunity with COVID-19 vaccines involves a range of factors, several of which are unknown.
Japan Times
WORLD / Science & Health
Nov 19, 2020
Pfizer-BioNTech coronavirus vaccine deliveries could start 'before Christmas'
Final trial results showed the vaccine had a 95% success rate and no serious side effects, the drugmakers said.
Japan Times
ASIA PACIFIC / Science & Health
Nov 18, 2020
China takes risk in rushing to use unproven coronavirus vaccines
China has made its unproven candidates widely available to demonstrate their safety and effectiveness to a country that has long been skeptical of vaccines.
Japan Times
ASIA PACIFIC / Science & Health
Nov 18, 2020
Sinovac's COVID-19 vaccine induces quick immune response, study finds
Sinovac Biotech's experimental COVID-19 vaccine CoronaVac triggered a quick immune response but the level of antibodies produced was lower than in people who had recovered from the disease, preliminary trial results showed on Wednesday.
Japan Times
WORLD / Science & Health
Nov 18, 2020
Pfizer reaches safety milestone for COVID-19 vaccine, CEO says
Pfizer Inc. Chief Executive Officer Albert Bourla said that a key safety milestone had been reached in the study of its COVID-19 vaccine, and the drugmaker is now preparing to seek an emergency-use authorization from U.S. regulators.
Japan Times
WORLD / Science & Health / FOCUS
Nov 18, 2020
How Pfizer and BioNTech sprinted ahead in extraordinary race for a COVID-19 vaccine
Researchers were asked to tackle something that had never been done before: design a vaccine to stop a pandemic in its tracks in less than a year.
Japan Times
WORLD / Science & Health
Nov 17, 2020
Moderna’s COVID-19 vaccine: What you need to know
Coming a week after similar news from Pfizer and BioNTech, Moderna's announcement offered more hope that there's going to be a way out of the pandemic.
Japan Times
WORLD / Science & Health
Nov 17, 2020
WHO warns against COVID-19 complacency after Moderna vaccine news
'Right now we are extremely concerned by the surge in cases we are seeing in some countries,' WHO director-general Tedros Adhanom Ghebreyesus told a news briefing.
Japan Times
WORLD / Science & Health
Nov 17, 2020
How the Moderna and Pfizer coronavirus vaccines stack up
The encouraging late-stage trial results from Pfizer Inc. and Moderna Inc. set a high bar for rivals that are expected to follow soon with their own pivotal reports.
Japan Times
WORLD
Nov 16, 2020
Drugmaker Moderna says COVID-19 vaccine shows nearly 95% protection
A key advantage of Moderna's vaccine is that it does not need ultracold storage like Pfizer's, making it easier to distribute.

Longform

Construction takes place on the Takanawa Gateway Convention Center in Tokyo, slated to open in 2025.
A boom for business tourism in Japan?